Recombinant Anti-SARS-CoV-2 S protein (NTD) Antibody (V3S-0623-XY135) (CAT#: V3S-0623-XY135)

Send Inquiry
  • fig1

Datasheet

MSDS

COA

Summary
Property
Applications
Protocols
Target

Summary

Description The antibody CV3-13 binds to SARS-CoV-2 spike protein. It binds from a distinct angle of approach to an N-terminal domain (NTD) epitope. The antibody does not alter the replication dynamics of SARS-CoV-2 in K18-hACE2 mice, but its Fc enhanced version significantly delays virus spread, neuroinvasion, and death in prophylactic settings. It is a non-nAb with potent Fc-mediated effector functions.
Clonality Monoclonal
Host Species Human
Target Species SARS-CoV-2
Epitope N-terminal domain (NTD)
Isotype IgG1

Property

Expression Species HEK293F or CHO cell line
Conjugation Unconjugated
Purity >95%
Endotoxin <1 EU/mg
Form Liquid
Purification Protein A purified
Sterility 0.2 μM filtered
Formulation PBS, pH 7.4
Preservation No preservatives
Stabilizer No stabilizers
Storage Store at 4°C within one or two weeks. Store at -20°C for long term. Avoid repeated freeze/thaw cycles. Refer to the COA file for specifics.

Applications

Application ELISA
Application Notes Recombinant SARS-CoV-2 S-6P, or BSA as a negative control, were prepared in PBS and were adsorbed to plates overnight at 4°C. Coated wells were subsequently blocked with blocking buffer for 1 h at room temperature. Wells were then washed four times with washing buffer. mAbs (50 ng/mL) were prepared in a diluted solution of blocking buffer and incubated in the coated wells for 90 min at room temperature. Plates were washed four times with washing buffer followed by incubation with HRP-conjugated anti-Human IgG secondary Abs for 1 h at room temperature, followed by four washes. HRP enzyme activity was determined after the addition of 40 μL of a 1:1 mix of Western Lightning oxidizing and luminol reagents.

Protocols

ELISA Enzyme-Linked Immunosorbent Assay Protocol
WB Western Blot Protocol
FC Western Blot Protocol

Target

Target SARS-CoV-2
Alternative Name Severe acute respiratory syndrome coronavirus 2
Research Area Coronavirus Disease 2019
Related Disease Coronavirus Disease 2019
For research use only, not directly for clinical use.
banner banner
© 2024 Creative Biolabs. All Rights Reserved.
antibody
Online Inquiry